Immunotherapy Combined With Radiation and Influenza Vaccine for Pancreatic Cancer.

Stopped Based on the precpecified interim analysis the predictive probability was below 10% for the prespecified endpoint.

Conditions

• Pancreatic Cancer

Interventions

• DRUG: Nivolumab
• DRUG: Ipilimumab
• BIOLOGICAL: Influenza vaccine
• RADIATION: SBRT

Sponsor

Herlev Hospital